Labcorp Announces 2025 Third Quarter Results and Updates Full-Year Guidance

Labcorp reported its third-quarter results for 2025, showing significant growth in revenue and earnings. The company's revenue increased to $3.56 billion from $3.28 billion in the same quarter of the previous year. Diluted earnings per share (EPS) rose to $3.12 from $2.00, while adjusted EPS increased to $4.18 from $3.50. Labcorp also updated its full-year guidance, adjusting its revenue growth forecast to 7.4% to 8.0%, with a slight reduction in the midpoint due to currency impacts and acquisition timing. The company raised its adjusted EPS guidance to a range of $16.15 to $16.50 and increased its free cash flow projection to $1.17 billion to $1.29 billion. Labcorp highlighted several strategic agreements with health systems and regional laboratories, advancements in high-growth specialty testing areas, and the introduction of new digital capabilities. The company also announced a quarterly cash dividend of $0.72 per share, payable in December 2025.